Search Results - "Kurtin, S"

PedsQL™ 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in Healthy and Patient Populations by Varni, James W., Seid, Michael, Kurtin, Paul S.

“…Background. The PedsQL (Pediatric Quality of Life Inventory) (Children's Hospital and Health Center, San Diego, California) is a modular instrument for…”
Get full text

A quality improvement project to increase breast milk use in very low birth weight infants by Lee, Henry C, Kurtin, Paul S, Wight, Nancy E, Chance, Kathy, Cucinotta-Fobes, Tracey, Hanson-Timpson, Tara A, Nisbet, Courtney C, Rhine, William D, Risingsun, Kate, Wood, Matthew, Danielsen, Beate H, Sharek, Paul J

“…To evaluate a multihospital collaborative designed to increase breast milk feeding in premature infants. Eleven NICUs in the California Perinatal Quality of…”
Get full text

Efficacy of Lenalidomide in Myelodysplastic Syndromes by List, Alan, Kurtin, Sandy, Roe, Denise J, Buresh, Andrew, Mahadevan, Daruka, Fuchs, Deborah, Rimsza, Lisa, Heaton, Ruth, Knight, Robert, Zeldis, Jerome B

“…In a study of 43 patients with low-risk myelodysplastic syndromes, lenalidomide, a thalidomide derivative, ameliorated anemia and allowed the discontinuation…”
Get full text

A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors by Mahadevan, D., Plummer, R., Squires, M.S., Rensvold, D., Kurtin, S., Pretzinger, C., Dragovich, T., Adams, J., Lock, V., Smith, D.M., Von Hoff, D., Calvert, H.

“…AT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs). Based on potent antitumor activity in preclinical models, a first-in-human clinical trial…”
Get full text

204 MDS PATIENT CHARACTERISTICS ASSOCIATED WITH USE OF DISEASE-MODIFYING THERAPY: RESULTS OF A PATIENT SURVEY by Kurtin, S, Chang, E, Bentley, T

Get full text

7 SYMPTOM BURDEN AND QUALITY OF LIFE AMONG PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): ANALYSIS OF SURVEY DATA by Kurtin, S, Chang, E, Bentley, T.G.K

Get full text

203 MDS CONCEPTUAL FRAMEWORK IDENTIFIES UNMET NEED FOR HMA-UNRESPONSIVE AND TRANSPLANT-INELIGIBLE PATIENTS by Bentley, T, Broder, M, Megaffin, S, Petrone, M, McKearn, T, Kurtin, S, Cogle, C

Get full text

354 Disease burden and treatment impact associated with myelodysplastic syndromes: Initial estimates by Demakos, E, Kurtin, S

Get full text

76 POPULATION INCIDENCE OF MDS FOLLOWING HYPOMETHYLATING AGENT (HMA) TREATMENT FAILURE: ANALYSIS OF US COMMERCIAL CLAIMS DATA by Cogle, C, Kurtin, S, Bentley, T, Broder, M, Chang, E, Lawrence, M, McKearn, T, Megaffin, S, Petrone, M

Get full text

Health-related quality of life as a predictor of pediatric healthcare costs: a two-year prospective cohort analysis by Seid, Michael, Varni, James W, Segall, Darron, Kurtin, Paul S

“…The objective of this study was to test the primary hypothesis that parent proxy-report of pediatric health-related quality of life (HRQL) would prospectively…”
Get full text

Lack of Health Maintenance Exams and Risk: An Internet-Based Survey on Health Maintenance and Preventive Care Patterns in Patients with Myeloma by Tariman, J.D, Gleason, C, Faiman, B, Doss, D, Catamero, D, Bishop-Royse, J, Katz, M, Kurtin, S, The IMF Nurse Leadership Board, Lonial, S

Get full text

220 EDUCATIONAL AND KNOWLEDGE GAPS AMONG COMMUNITY HEALTH CARE PROVIDERS (HCPS) TREATING PATIENTS WITH LOWER-RISK MDS by Kurtin, S, Latsko, J, Finley-Oliver, E

Get full text

Parents' Perceptions of Primary Care: Measuring Parents' Experiences of Pediatric Primary Care Quality by Seid, Michael, Varni, James W, Bermudez, Laura Olson, Zivkovic, Mirjana, Far, Maryam Davodi, Nelson, Melissa, Kurtin, Paul S

“…A measure of pediatric primary care quality that is brief, practical, reliable, and valid would be useful to patients and pediatricians, policymakers, and…”
Get full text

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes by McGraw, K L, Zhang, L M, Rollison, D E, Basiorka, A A, Fulp, W, Rawal, B, Jerez, A, Billingsley, D L, Lin, H-Y, Kurtin, S E, Yoder, S, Zhang, Y, Guinta, K, Mallo, M, Solé, F, Calasanz, M J, Cervera, J, Such, E, González, T, Nevill, T J, Haferlach, T, Smith, A E, Kulasekararaj, A, Mufti, G, Karsan, A, Maciejewski, J P, Sokol, L, Epling-Burnette, P K, Wei, S, List, A F

“…Nonsynonymous TP53 exon 4 single-nucleotide polymorphism (SNP), R72P, is linked to cancer and mutagen susceptibility. R72P associations with specific cancer…”
Get full text

Between ‘desperation’ and disability rights: a narrative analysis of complementary/alternative medicine use by parents for children with Down syndrome by Prussing, Erica, Sobo, Elisa J., Walker, Elizabeth, Kurtin, Paul S.

“…This paper presents a narrative analysis of complementary/alternative medicine (CAM) use by parents for children with Down syndrome (DS), based on interviews…”
Get full text

Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia by Buresh, A, Perentesis, J, Rimsza, L, Kurtin, S, Heaton, R, Sugrue, M, List, A

Get full text

Monitoring dialysis patients' health status by Meyer, K B, Espindle, D M, DeGiacomo, J M, Jenuleson, C S, Kurtin, P S, Davies, A R

“…We report 3 years of experience with quarterly assessments of the self-reported health of dialysis outpatients using the Short Form-36 (SF-36) Health Survey…”
Get more information

C028 Cytogenetic response to lenalidomide is associated with improved survival in patients with chromosome 5q deletion by List, A.F, Wride, K, Dewald, G.W, Bennett, J.M, Giagounidis, A, Kurtin, S, Knight, R.D

Get full text

Outcomes assessment: meeting the challenge of accountability in pediatric rheumatology by Kurtin, P S

“…As providers of health services, pediatric rheumatologists must learn to manage financial risk, deliver quality services, and provide value to a number of…”
Get more information

Integrating Biomarker Testing into EHR Systems: Implications for the Laboratory Based on Findings from a Multistakeholder Summit by Offit, C, Emara, R, Alvarez, B, Lile, A, Plotkin, E, Starks, R, Schiller, M, McNair, C, Kim, J, Waugh, W, Huelsman, K, Kurtin, S, Yu, P, Martin, N

“…Abstract Introduction/Objective Guideline-driven tumor biomarker testing remains standard of care for precision oncology due to the increasing number of…”
Get full text